TY - JOUR T1 - APPLAUSE: Automatic Prediction of PLAcental health via U-net Segmentation and statistical Evaluation JF - medRxiv DO - 10.1101/2020.09.22.20199521 SP - 2020.09.22.20199521 AU - Maximilian Pietsch AU - Alison Ho AU - Alessia Bardanzellu AU - Aya Mutaz Ahmad Zeidan AU - Lucy C. Chappell AU - Joseph V. Hajnal AU - Mary Rutherford AU - Jana Hutter Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/23/2020.09.22.20199521.abstract N2 - Purpose Artificial-intelligence population-based automated quantification of placental maturation and health from a rapid functional Magnetic Resonance scan. The placenta plays a crucial role for any successful human pregnancy. Deviations from the normal dynamic maturation throughout gestation are closely linked to major pregnancy complications. Antenatal assessment in-vivo using T2* relaxometry has shown great promise to inform management and possible interventions but clinical translation is hampered by time consuming manual segmentation and analysis techniques based on comparison against normative curves over gestation.Methods This study proposes a fully automatic pipeline to predict the biological age and health of the placenta based on a rapid (sub-30 second) T2* scan in two steps: Automatic segmentation using a U-Net and a Gaussian Process regression model to characterize placental maturation and health. These are trained and evaluated on 110 3T MRI placental data sets including 20 high-risk pregnancies diagnosed with pre-eclampsia and/or fetal growth restriction.Results Automatic segmentation achieves comparable performance to human experts (mean DICE coefficients automatic-manual 0.76, Pearson Correlation Coefficient 0.986 for mean T2* within the masks). The placental health prediction achieves an excellent ability to differentiate early cases of placental in-sufficiency before 32 weeks. High abnormality scores correlate with low birth weight, premature birth and histopathological findings. Retrospective application on a different cohort imaged at 1.5T illustrates the ability for direct clinical translation.Conclusion The presented automatic pipeline facilitates a fast, robust and reliable prediction of placental maturation. It yields human-interpretable and verifiable intermediate results and quantifies uncertainties on the cohort-level and for individual predictions. The proposed machine-learning pipeline runs in close to real-time and, deployed in clinical settings, has the potential to become a cornerstone of diagnosis and intervention of placental insufficiency.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work received funding from the NIH Human Placenta Project grant [1U01HD087202-01] European Research Council under the European Union's Seventh Framework Programme [FP7/20072013]/ERC grant agreement no. [319456] (dHCP project), and was supported by the Wellcome EPSRC Centre for Medical Engineering at Kings College London [WT 203148/Z/16/Z], Wellcome Trust Sir Henry Wellcome Fellowship and Open Science Enrichment award, MRC strategic grant [MR/K006355/1] and by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The authors thank all involved radiographers, research midwifes and participating mothers for their invaluable help.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Riverside Ethics committee: REC 14/LO/1169, https://placentaimagingproject.org/All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMedical imaging data is not made publicly available. Derived data and Gaussian Process analysis source code are made available. https://osf.io/fbcsa/?view_only=324ffb5712f545aa8885f11261615857 ER -